Net profit soared to 259 million euros ($281 million) in the first three months of 2017, compared with 37 million euros in the same period last year.
The year-earlier figure had been down some 63 per cent, due mainly to taxes linked to its efforts to divest the lighting business.
Also Read
"We had a solid start to the year," chief executive Frans van Houten said.
"As we become a clearer company there are less incidentals, so it is the absence of incidentals that have actually increased the profit," he told reporters on a conference call.
He highlighted "continued volatility in the markets in which we operate" but stressed that "our HealthTech portfolio grew three percent and achieved further operational improvements."
Philips was best known for the manufacture of lightbulbs, electrical appliances and television sets.
But it pulled out of these activities in face of fierce competition from Asia to focus on health technology such as computer tomography, and diagnostic and molecular imaging.
It also manufacturers such vital medical equipment as defibrillators, as well as household appliances - from electrical and hi-tech toothbrushes to kitchen equipment.
The group, which sold its first lightbulb a few years after it was founded in 1891, listed its Philips Lighting division at the end of May, netting proceeds of 750 million euros.
Philips further reduced its shareholding in Philips Lighting to 55 per cent, selling a further 26 million shares on February 8.
Shareholders had responded well, Van Houten said. "It was always our strategy to participate in the value creation that Philips Lighting represents, therefore we are not in a hurry to sell down our stake," he said.
The stake would be sold down over the next two years or so, he added, but refused to be drawn about when the next tranche of shares would be released.
In the United States the market remained "flat" due to a period of hospital consolidation, as well as US President Donald Trump's vow to reform the health care system.
"All the upheaval around the accountable care act, certainly led some hospitals to be cautious about capital investment," Van Houten said.
Hospitals are "not sure how it would affect the Medicare-Medicaid patient base... So that uncertainty means the market is kind of flat."
While that uncertainty was likely to last into the second quarter, he added Philips had seen strong orders coming from China and India, as well as Europe and that "somewhat compensates for the slower US market.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)